Cannabis compounds are being used to tackle kidney failure amongst diabetics in a major new research project. Researchers working on the Aberdeen University study, which is funded by Diabetes UK, will explore whether synthetic cannabinoid compounds can be used to make the kidneys respond better to insulin.
Hannah Loew, a child who suffers from a severe form of epilepsy called Dravet Syndrome, is among dozens who have moved to Colorado to receive higher concentrated doses of marijuana.